Screener
Candel Therapeutics, Inc. CADL Operating margin
Discontinued — last reported Q4 '22
Operating margin at other companies
Other financials
Where this comes from
Calculated from Candel Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Candel Therapeutics, Inc.’s 10-K, filed March 28, 2024. Open the filing →
- Filed
- Mar 28, 2024
- Fiscal year
- FY2023
- Accession
- 0000950170-24-037637
FAQ
- What is Candel Therapeutics, Inc.'s operating margin?
- Candel Therapeutics, Inc. (CADL) reported operating margin of -28,000.8% in Q4 2022.
- How has Candel Therapeutics, Inc.'s operating margin changed year-over-year?
- Candel Therapeutics, Inc.'s operating margin decreased by 35.0% year-over-year, from -20,747.6% to -28,000.8%.
- What is the long-term trend for Candel Therapeutics, Inc.'s operating margin?
- Over 2 years (2020 to 2022), Candel Therapeutics, Inc.'s operating margin has grown at a 59.2% compound annual growth rate (CAGR), from -11,048% to -28,000.8%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Candel Therapeutics, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude